Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1)
E. Blaveri et al., Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1), EUR J HUM G, 9(6), 2001, pp. 469-472
Schizophrenia is a common, genetically heterogeneous disorder with a lifeti
me prevalence of approximately 1% in the general population. Linkage studie
s of affected families have now strongly implicated a susceptibility locus
on chromosome 8p21-22. Tests of allelic association with markers on 8p21-22
should be able to localise any quantitative trait nucleotides (QTN's) or s
usceptibility mutations to within a few hundred kilobases. Three brain expr
essed candidate susceptibility genes, prepronociceptin (PNOC), neuronal cho
linergic receptor, nicotinic, alpha polypeptide 2 (CHRNA2) and arylamine N-
acetyltransferase 1 (NAT1) have been mapped to chromosome 8p21-22. A case-c
ontrol, allelic association study was performed using a novel highly polymo
rphic dinucleotide repeat, D8S2611 near the PNOC gene, two previously chara
cterised dinucleotide repeats, D8S131 and D8S131P at the CHRNA2 locus and a
n RFLP at the 3 ' UTR of the arylamine N-acetyltransferase 1 (NAT1) gene. N
o differences were found in allele frequencies between the patient and cont
rol groups. DNA variations or mutations at or near the three genes under st
udy are unlikely to increase susceptibility to schizophrenia in our populat
ion sample.